Sakar Healthcare Ltd. Live Share Price Today, Share Analysis and Chart

Name: Sakar Healthcare Ltd.: Is Infosys Ltd. worth buying?
Item: Sakar Healthcare Ltd.
Rating: 3.300083375
Author: Trendlyne DVM scores

Mid-range Performer

about

Sakar Healthcare is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectable (SVP) in Ampoules,Vials & Lyophilized Injections, Oral Solid Dos...

347.60 -2.35 (-0.67%)

65.45% Gain from 52W Low

10,723

NSE Volume

NSE 30 Jul, 2025 3:31 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

High Financial Strength

80.0 / 100

Mid Valuation

45.2 / 100

Technically Neutral

58.8 / 100

Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM

No estimates available

Sakar Healthcare Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Is Sakar Healthcare Ltd. worth buying?

40 Votes:

Buy 87.5%

Sell 5.0%

Hold 7.5%

Sakar Healthcare Ltd. Live Share Price Today, Share Analysis and Chart

Sakar Healthcare is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectable (SVP) in Ampoules,Vials & Lyophilized Injections, Oral Solid Dos...

65.45% Gain from 52W Low

SWOT Analysis

Sakar Healthcare Live Price Chart